Serum sclerostin is decreased following vitamin D treatment in young vitamin D-deficient female adults

被引：16

作者：

Cidem, Muharrem ^{[1
]}

Karacan, Ilhan ^{[1
]}

Arat, Neval Bozok ^{[1
]}

Zengi, Oguzhan ^{[2
]}

Ozkaya, Murat ^{[1
]}

Guzel, Saadet Pilten ^{[2
]}

Ozkan, Cansu ^{[1
]}

Beytemur, Ozan ^{[3
]}

机构：

[1] Bagcilar Training & Res Hosp, Dept Phys Med & Rehabil, Istanbul, Turkey

[2] Bagcilar Training & Res Hosp, Dept Biochem, Istanbul, Turkey

[3] Bagcilar Training & Res Hosp, Orthopaed & Traumatol Dept, Istanbul, Turkey

来源：

RHEUMATOLOGY INTERNATIONAL | 2015年 / 35卷 / 10期

关键词：

Sclerostin; 25-Hydroxyvitamin D; Osteomalacia; BONE; CALCIUM;

D O I：

10.1007/s00296-015-3294-1

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

Sclerostin is produced almost exclusively by osteocytes, which also express receptors for 1,25 dihydroxyvitamin D3. The aim of this study was to investigate the effects of vitamin D3 treatment on serum sclerostin levels in young adult females with severe vitamin D deficiency. A total of 26 subjects were treated orally with calcium (1.200 mg/day for 2 months) and vitamin D3 (300.000 IU/week for 1 month). Serum 25-hydroxyvitamin D (25(OH)D) and sclerostin levels were measured before and after treatment. Baseline serum 25(OH)D and sclerostin levels were at 5.7 +/- A 2.4 ng/mL and 39.1 +/- A 14.4 pg/mL, respectively. Serum 25(OH)D was significantly increased, to 62.4 +/- A 18.7 ng/mL, following treatment; serum sclerostin was significantly decreased, to 29.3 +/- A 8.8 pg/mL. We conclude that serum sclerostin level is decreased following vitamin D3 treatment in patients with vitamin D deficiency.

引用

页码：1739 / 1742

页数：4

共 16 条

[1]

SOST/sclerostin, an osteocyte-derived negative regulator of bone formation [J].

Bezooijen, RL ;

ten Dijke, P ;

Papapoulos, SE ;

Löwik, CWGM .

CYTOKINE & GROWTH FACTOR REVIEWS, 2005, 16 (03) :319-327

[2]

Mechanotransduction in bone - role of the lacuno-canalicular network [J].

Burger, EH ;

Klein-Nulend, J .

FASEB JOURNAL, 1999, 13 :S101-S112

[3]

Cidem M, 2013, J CLIN EXP INVEST, V4, P488, DOI DOI 10.5799/AHINJS.01.2013.04.0330

[4]

Effects of Sex Steroids on Serum Sclerostin Levels during the Menstrual Cycle [J].

Cidem, Muharrem ;

Usta, Taner A. ;

Karacan, Ilhan ;

Kucuk, Suat Hayri ;

Uludag, Murat ;

Gun, Kerem .

GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2013, 75 (03) :179-184

[5]

Sclerostin: Therapeutic Horizons Based Upon Its Actions [J].

Costa, Aline G. ;

Bilezikian, John P. .

CURRENT OSTEOPOROSIS REPORTS, 2012, 10 (01) :64-72

[6]

Effect of supplemental vitamin D and calcium on serum sclerostin levels [J].

Dawson-Hughes, Bess ;

Harris, Susan S. ;

Ceglia, Lisa ;

Palermo, Nancy J. .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 170 (04) :645-650

[7]

Increased Sclerostin Serum Levels Associated with Bone Formation and Resorption Markers in Patients with Immobilization-Induced Bone Loss [J].

Gaudio, Agostino ;

Pennisi, Pietra ;

Bratengeier, Cornelia ;

Torrisi, Venerando ;

Lindner, Brigitte ;

Mangiafico, Roberto A. ;

Pulvirenti, Ivana ;

Hawa, Gerhard ;

Tringali, Giovanni ;

Fiore, Carmelo E. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (05) :2248-2253

[8]

Effects of vitamin D in skeletal muscle: falls, strength, athletic performance and insulin sensitivity [J].

Girgis, Christian M. ;

Clifton-Bligh, Roderick J. ;

Turner, Nigel ;

Lau, Sue Lynn ;

Gunton, Jenny E. .

CLINICAL ENDOCRINOLOGY, 2014, 80 (02) :169-181

[9]

Resurrection of vitamin D deficiency and rickets [J].

Holick, Michael F. .

JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (08) :2062-2072

[10]

Lombardi G, 2012, J BIOL REG HOMEOS AG, V26, P157

← 1 2 →